As a leader in the area of Neuroscience, Janssen is oriented to the development of medications for the treatment of diverse neurologic and psychiatric pathologies, as well as for moderate to severe pain.

With more than 50 years of experience in this therapeutic area, Janssen has shown its capability and commitment in providing innovative solutions for diverse disorders as migraine, epilepsy, attention deficit hyperactivity disorder (ADHD), schizophrenia and bipolar disorder amongst others. Janssen is at the forefront in treatment for these type of pathologies.